Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)-

Request For Quotation

Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)- manufacturers

  • AZD5718
  • AZD5718 pictures
  • $2800.00
  • 2026-05-11
  • CAS:2041076-43-9
  • Purity:
  • Supply Ability: 10g
Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)- Basic information
Product Name:Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)-
Synonyms:Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)-
CAS:2041076-43-9
MF:C29H34N6O4
MW:530.62
EINECS:
Product Categories:
Mol File:2041076-43-9.mol
Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)- Structure
Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)- Chemical Properties
Boiling point 857.5±65.0 °C(Predicted)
density 1.45±0.1 g/cm3(Predicted)
pka13.14±0.20(Predicted)
Safety Information
MSDS Information
Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)- Usage And Synthesis
UsesFLAP-IN-1 (Intermediate 14) is a 5-lipoxygenase-activating protein (FLAP) inhibitor with an IC50 value of 654 nM. FLAP-IN-1 can be used in cardiovascular disease research[1].
References[1] Johan Olof BRODDEFALK, et al. Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitors. WO2016177703A1. 2016-11-10.
Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)- Preparation Products And Raw materials
Tag:Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)-(2041076-43-9) Related Product Information
AZD 5718) Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)- GSK2190915 (S)-BI 665915 Thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 3-hydroxy-7-(phenylsulfonyl)- 10H-Pyridazino[1′,6′:4,5]pyrazino[2,1-c][1,4]oxazine-3,5-dione, 2-[(1S)-1-(1-chloro-2-naphthalenyl)ethoxy]-7,8,10a,11-tetrahydro-4-hydroxy-, (10aS)-